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Eicosapentaenoic acid suppresses PDGF-induced DNA
synthesis in rat mesangial cells: Involvement of thromboxane A2
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that TXA2 functions as a comitogen for PDGF-stimulated mes-Eicosapentaenoic acid suppresses PDGF-induced DNA syn-
angial cell growth.thesis in rat mesangial cells: Involvement of thromboxane A2.
Background. The administration of eicosapentaenoic acid
(EPA) derived from marine oils has been shown to suppress
vascular myocyte, lymphocyte, keratinocyte, and mesangial cell
Adaptive changes in cell membrane lipid compositionproliferation in vitro, although the effects are variable and
after chronic exposure to long-chain polyunsaturatedmost reports provide fragmented insight into the mechanism(s)
responsible for altering cell growth, particularly the relation- fatty acids of the v-3 series are believed to contribute
ship of membrane lipid remodeling to changes in cell prolifera- to the biophysiologic actions of diets enriched with ma-
tion. Thus, these studies were designed to elucidate the effects rine oil [1]. The functional effects of membrane incorpo-
of mesangial cell membrane fatty acid remodeling (induced by
ration of v-3 fatty acids may include the modulationEPA) on cell growth, and to define the relevance of changes
of signal transduction originating from membrane lipidin the synthesis of growth-modulating eicosanoids.
Methods. Mesangial cells were grown in RPMI and 17% turnover such as endogenous prostaglandin synthesis
fetal calf serum, and were subcultured and grown for 48 hours [2, 3], alterations in ligand–receptor coupling [4, 5], or
in 17% delipidated serum or delipidated serum supplemented changes in the molecular composition of phospholipidwith 0 to 50 mg/mL of EPA. Quiescent EPA-loaded and control
second messengers [6]. Recently, the consequences ofmesangial cells were subjected to stimulation with 20 ng/mL
fatty acid manipulations on cell growth and differentia-of platelet-derived growth factor (PDGF) followed by mea-
surement of 3H-thymidine incorporation and cell number. tion have been described in vascular smooth muscle cells
Results. Mesangial cells remodeled with EPA exhibited a [7], keratinocytes [8], epithelial cells [9], and mesangial
significant decrease in PDGF-stimulated 3H-thymidine incor- cells [10]. Exposure of these cells to v-3 fatty acids sup-poration and cell number associated with a reduction in throm-
pressed proliferation provoked by polypeptide growthboxane A2 (TXA2) in the media. Importantly, the phospholipid
factors such as platelet-derived growth factor (PDGF)fatty acid composition of mesangial cells grown in media en-
riched with EPA revealed an increase in EPA (0.5 6 0.02% and epidermal growth factor. Moreover, diets enriched
to 17.02 6 0.52%) coupled with a reciprocal decrease in the with v-3 fatty acids have been shown to prevent malig-
precursor for TXA2, arachidonic acid (18.19 6 3.17% to 3.55 6 nant transformation (and presumably cell proliferation)0.30%). Blockade of TXA2 synthesis in mesangial cells treated
in experimental models of colon cancer [11]. However,with indomethacin (0.1 to 100 mmol/L) or the specific TXA2
synthase inhibitor, U-63557A (0.1 to 100 mmol/L), evoked a the mechanisms responsible for changes in cell growth
similar reduction in PDGF-stimulated proliferation and TXA2 in these settings are ill-defined.
synthesis. Coincubation of PDGF with the TXA2 mimetic, U- Importantly, glomerular mesangial cell proliferation46619 (1 mmol/L), reversed the growth suppression induced
is a frequent finding in experimental renal disease, andby cell membrane remodeling.
thus, agents that modulate mesangial cell growth offerConclusions. These studies suggest that changes in mem-
brane fatty acid composition induced by EPA modulates promise in the management of progressive renal disease.
PDGF-stimulated proliferation by engendering a change in For example, consumption of diets enriched with v-3
PDGF-stimulated TXA2 synthesis. Furthermore, we conclude fatty acids has been shown to retard progressive renal
injury in experimental models of renal disease [12]. Simi-
lar beneficial findings have been reported in clinical renalKey words: mesangium, platelet-derived growth factor, cell division,
fatty acids. disease, including IgA nephropathy and renal allograft
rejection [13, 14]. Thus, defining the effects of v-3 fatty
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v-3 fatty acids on membrane fatty acid composition and in T-75 flasks were trypsinized and plated (5 3 104 cells/
changes in cell growth have not been examined. The well) on 24-well plates prior to incubation with EPA-
latter is particularly noteworthy given the lack of atten- enriched media. Following attachment (4 to 7 days), cells
tion to the effects of fatty acid dose on membrane fatty were grown in media enriched with 0 to 50 mg/mL EPA
acid composition and biological response in virtually all (Sigma Chemical Co.) for 48 hours to enable steady-
published reports. Indeed, these uncertainties may un- state incorporation of fatty acids within cell membrane
derlie the inexplicable disparity in outcomes obtained phospholipid pools. Cells were washed copiously with
among studies examining the effects of v-3 fatty acids phosphate-buffered saline (PBS) to remove residual su-
in vivo and in vitro. pernatant EPA and were either prepared for DNA syn-
Thus, the present studies were undertaken to test the thesis as described later in this article, or were scraped
hypothesis that membrane fatty acid remodeling incur- and fractionated into particulate and soluble fractions;
red by exposure to v-3 fatty acids is requisite to inhib- the particulate fraction was subsequently analyzed for
it mesangial cell proliferation. Eicosapentaenoic acid fatty acid composition (discussed later in this article).
(EPA) was used as the surrogate v-3 fatty acid, because Study 2. Effects of eicosapentaenoic acid on prostaglan-
this fatty acid is the most abundant v-3 fatty acid in din E2 and thromboxane B2 synthesis. Because alter-marine oils and is readily incorporated into phospholipid
ations in various prostaglandin metabolites have been
fatty acid pools [15, 16].
implicated in the control of mesangial cell growth, weThe studies reported herein demonstrate suppression
also examined quiescent and growth-stimulated prosta-of mitogenesis following membrane incorporation of
glandin metabolites derived from mesangial cells [18,EPA only when the membrane content of the precursor
19]. These experiments were carried out in control cellsfor thromboxane A2 (TXA2), arachidonic acid, was re-
and cells enriched with EPA, as described in study 1.duced to 10% or lower of the total fatty acid content.
Supernatants for basal determinations of prostaglandinFurther decreases in arachidonic acid were accompanied
E2 (PGE2) and TXB2 (discussed later in this article) wereby a reciprocal decrease in TXA2 synthesis and growth,
collected after stimulation with 20 ng/mL PDGF (PDGF-suggesting a link between membrane fatty acid content,
BB; Sigma Chemical Co.) 3 24 hours.TXA2 synthesis, and cell growth. Accordingly, subse-
Study 3. Effects of indomethacin and U-63557A onquent studies using specific inhibitors of cyclooxygenase
DNA synthesis. Because the concentration of superna-and thromboxane synthase revealed the dependency of
tant TXB2 paralleled the decrease in DNA synthesis, itmesangial cell growth on TXA2. Finally, restoration of
cell growth with the TXA2 mimetic, U-46619, provided was hypothesized that a reduction in TXA2 generation
strong evidence that TXA2 is required to mediate the was responsible for the attendant growth suppression.
integral growth response induced by PDGF. It was therefore reasoned that pharmacological inhibi-
tion of TXA2 synthesis would also result in growth sup-
pression in mesangial cells. Accordingly, DNA synthesisMETHODS
was quantitated in cells treated for 24 hours with 0.1
Experimental design
to 100 mmol/L of the cyclooxygenase inhibitor, indom-
All experiments were carried out using rat glomerular ethacin (Sigma Chemical Co.). Although inhibition of
mesangial cells from the fourth to sixth passage, ensuring cyclooxygenase resulted in suppressed growth, it was not
uniformity of cell response. Cells were grown in appro- possible to distinguish the effects of inhibition of TXA2
priate tissue culture vessels containing RPMI and 17% from inhibition of other cyclooxygenase metabolites, for
fetal calf serum (Sigma Chemical Co., St. Louis, MO, example, PGE2. Therefore, selective inhibition of TXA2USA). Cells were washed with RPMI without serum and
synthase was quantitated in cells treated for 24 hours
then reincubated in the following media for 48 hours: (1)
with 0.1 to 100 mmol/L of the selective TXA2 synthaseRPMI with 17% delipidated serum served as a control or
antagonist, U-63557A (kindly provided by the Upjohn(2) RPMI with delipidated serum enriched with EPA
Company, Kalamazoo, MI, USA) [20].(complexed to fatty acid free bovine serum albumin)
Study 4. Effects of coincubation of PDGF with U-46619at a concentration range of 10 to 50 mg/mL of media.
on DNA synthesis. To further assess the contribution ofIncorporation of EPA into cell phospholipid pools was
decreased TXA2 synthesis to the growth inhibitory effectamplified (unpublished observations) by incubating mes-
induced by membrane fatty acid remodeling, 1 mmol/Langial cells in the presence of delipidated sera (Cocalico
of U-46619 (Cayman Chemical Co., Ann Arbor, MI,Biologicals, Reamstown, PA, USA), presumably by lim-
USA) was coincubated with PDGF 3 24 hours in controliting competition for uptake by other long-chain fatty
cells and cells subjected to pretreatment with EPA fol-acids [17].
lowed by determination of 3H-thymidine incorporationStudy 1. Effects of eicosapentaenoic acid on fatty acid
composition and DNA synthesis. Mesangial cells grown and cell number, as described later in this article.
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Mesangial cell culture of either delipidated sera (Cocalico Biologicals) or delip-
idated sera enriched with EPA (10 to 50 mg/mL media)Mesangial cell cultures obtained from Sprague-Daw-
for 48 hours. To ensure that lipid peroxidation was notley rats were established as previously described [21].
contributing to the antiproliferative effects of EPA, mes-Briefly, following the removal of the renal capsule, the
angial cells were rendered quiescent in the presence ofcortex was minced and passed through a series of stain-
2% fetal calf serum (discussed later in this article). Quies-less steel sieves (80, 150, 200 mesh) under sterile con-
cent cells were washed copiously with PBS and resus-ditions. After washing the glomerular pellet twice
pended in 2% delipidated sera 3 48 hours and then(2000 g 3 3 min), the pellet was incubated (378C) with
subjected to stimulation with PDGF-BB (20 ng/mL) forcollagenase (type II, 0.02%; Sigma Chemical Co.) in
24 hours. One-half mCi/mL of 3H-thymidine was addedRPMI (1% l-glutamine supplemented with 15 mmol/L/
to the cell culture media (Amersham Corp., ArlingtonL HEPES, penicillin 100 U/mL, streptomycin 100 U/mL,
Heights, IL, USA) during the last two hours of the incu-and insulin 0.06 units/mL) for 30 minutes. Glomeruli
bation. Each well was washed with cold PBS 3 2, andwere washed twice with media and supplemented with
trypsin EDTA was added to detach the cells. One millili-17% fetal calf serum. The glomerular suspension was
ter of 20% TCA was added to each well, followed by athen seeded on plastic tissue culture vessels and kept at
60-minute incubation at 48C. The TCA insoluble fraction378C in an atmosphere of 5% CO2. Fresh medium was
was collected on glass filter fibers (934AH; Whatman,added every three days. Primary mesangial cell out-
Inc., Clifton, NJ, USA) with a cell fractionater, and thegrowths began in one to two weeks, ultimately forming
radioactivity was determined using a liquid scintillationridges and hillocks in two to three weeks. For selective
spectrometer (Model LS 230; Beckman Instruments,passaging of mesangial cells, mesangial cells were de-
Inc., Fullerton, CA, USA). To confirm cell viability, astached using trypsin ethylenediaminetetraacetic acid
well as the results obtained using 3H-thymidine incorpo-(EDTA; 0.02%; Sigma Chemical Co.) and replated. Mes-
ration, a cell proliferation assay using the tetrazoliumangial cells were identified by their characteristic mor-
salt MTT (Roche Molecular Biochemicals, Indianapolis,phological and immunocytochemical features [22].
IN, USA) was performed, and cells were also counted
using a hemocytometer.Preparation of fatty acid-albumin complexes
Incorporation of long-chain fatty acids into cell mem- Membrane fractionation
brane phospholipids is facilitated by incubating cells with Mesangial cells were rinsed twice with ice-cold saline,
fatty acids complexed to albumin [23]. Thus, fatty acid- and 0.4 mL of cold lysis buffer was added (containing,
albumin complexes were prepared using a modification in mmol/L, 25 HEPES, 1 EGTA, 1 EDTA, 1 dithiothrei-
of the method of Spector and Hoak [24]. Chromato- tol, 250 sucrose, and 1 phenylmethylsulfonyl fluoride,
graphically pure free EPA (99%) was obtained from pH 7.4, 40 mg/mL leupeptin). The cells were scraped and
Sigma Chemical Co. The fatty acid was first loaded onto sonicated twice for 5 seconds and centrifuged at 100,000 g
dried adsorbent powder (Celite) in a 1:10 (mmol/L fatty for 40 minutes. The supernatant (cytosolic fraction) was
acid:g powder) ratio. Enough hexane was used to im- collected, and the pellet was resuspended in lysis buffer
merse the particles completely. The hexane was evapo- with 1% Triton X–100, sonicated twice for 5 seconds,
rated under nitrogen, and the dry, fatty acid-loaded parti- incubated on ice for 60 minutes, and centrifuged at
cles were added to a 20% solution of fatty acid-free 100,000 g for 40 minutes. The supernatant (particulate
bovine serum albumin (Sigma Chemical Co.). The mix- fraction) was subsequently purified on O-diethylamino-
ture was incubated for 30 minutes with gentle stirring ethyl Sephacel and prepared for fatty acid determina-
followed by centrifugation at 28C for 10 minutes at tions, as described later in this article.
15,000 g. The supernatant, which consists of fatty acid
Phospholipid fatty acid determinationscomplexed to albumin, was passed through a Millipore
filter of pore size 1.2 mm2, and the pH of the media was Fatty acid composition of the mesangial cell mem-
adjusted to 7.4. The final molar ratio of fatty acid to brane phospholipid pool was analyzed as previously de-
albumin was approximately 4:1. Aliquots of EPA-albu- scribed [25]. Lipid extracts obtained from the particulate
min were then added to the media to achieve concentra- fraction were fractionated on a 0.2 3 45 cm silicic acid
tions of 10 to 50 mg/mL of media. column treated with ammonium hydroxide [26]. High-
performance liquid chromatography was performed with
DNA synthesis and cell growth a Waters Model 501/740 data module/481 spectropho-
3H-thymidine incorporation was used to study DNA tometer (Millipore, Inc., Milford, MA, USA). The sol-
biosynthesis in mesangial cells. Mesangial cells were vent flow rate was set to 0.6 mL/min at 1000 psi (UK6
plated into 24-well dishes (5 3 104 cells/well), grown to injector). Fractionation of the extracts was accomplished
by first eluting cholesterol esters, triacylglycerols, andnear confluence, washed, and then grown in the presence
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other nonpolar lipids with methylene chloride. Next, ple comparison procedure. All statistical analyses were
performed on a Power Macintosh computer using thechloroform/methylene chloride (1:1, vol:vol) was passed
through the column for 10 minutes to elute cholesterol. Staview statistical software package for the social sci-
ences (SPSS, Chicago, IL, USA). All data are expressedThe triacylglycerol and phospholipids were isolated by
thin layer chromatography using silica gel H glass plates. as the mean 6 SEM.
The plates were developed in a solvent system of petro-
leum ether:dimethyl ether:acetic acid (100:25:1). The
RESULTS
triacylglycerol and phospholipid bands were visual-
Study 1ized using dichlorofluorescein and ultraviolet light. The
methyl esters of the phospholipid fraction were subse- Membrane incorporation of EPA was achieved in a
dose-dependent fashion in cultured glomerular mesan-quently prepared by transesterification using hexane.
The fatty acid methyl esters were then subjected to chro- gial cells (Table 1). EPA content increased from ,1%
in untreated cells to 17.02 6 0.5% in cells incubated withmatography using a Varian Model 3500 capillary gas
chromatograph equipped with a flame ionization detec- 50 mg/mL of EPA. A corresponding dose-dependent de-
crease of arachidonic acid from 18.19 6 3.17% in controltor and a 30 meter capillary column (Supelcowax 10;
Supelco, Inc., Bellefonte, PA, USA). The column tem- cells to 3.5 6 0.3% in cells pretreated with 50 mg/mL
EPA was also observed. Minor changes of other long-perature was programmed from 1758C to 2128C with a
ramp of 1.58C per minute and a final hold of 17 minutes. chain fatty acids, including palmitic and stearic acid, were
observed at the highest dose of EPA used. Importantly,
Detection of lipid peroxidation the fatty acid composition achieved in the cell membrane
with 20 to 50 mg/mL of EPA was similar to that observedMembrane obtained from cells grown in EPA-enriched
media was analyzed for lipid radical formation (malondi- in the intact glomerulus of rats fed diets enriched with
marine oil, thus establishing the relevance of this modelaldehyde), as previously described [27]. Membrane pro-
tein (0.1 mg) was combined with 2 mL of TCA/TBA/ to previous in vivo studies from our laboratory and en-
suring that the in vitro experiments would not simplyHCl (15% wt/vol trichloroacetic acid; 0.375% wt/vol thi-
obarbituric acid; 0.25 N hydrochloric acid), mixed thor- represent a supraphysiologic paradigm [29].
To ensure that subsequent studies of DNA synthesisoughly, and heated for 15 minutes at 1008C. The sample
was cooled, and the flocculent precipitate was removed were not influenced by the presence of lipid radical for-
mation, malondialdehyde levels were obtained in mesan-by centrifuging at 1000 g for 10 minutes. The absorbance
of the sample was determined at 535 nm against a blank gial cells pretreated with varying concentrations of EPA.
Determination of thiobarbituric acid-reactive substancescontaining all of the reagents minus the lipid. Malondial-
dehyde concentration was calculated using an extinction in cells pretreated with EPA and subsequently grown
for 48 hours in the presence of 17% fetal calf serumcoefficient of 1.56 3 1025 mol/L21 cm21 [28].
revealed an insignificant change in malondialdehyde
Immunoassay of prostaglandins concentration (Fig. 1). However, when fatty acid-remod-
eled cells were grown in the complete absence of serum,Specific antibody to PGE2 and TXB2 (stable metabo-
lite of TXA2) was used to determine prostaglandin con- malondialdehyde levels increased significantly within 48
hours of incubation (particularly when the cells werecentrations in cell supernatants as previously described
[29]. The antisera for these studies (Cayman Chemical pretreated with $30 mg/mL of EPA). Conversely, when
EPA-enriched mesangial cells were grown in the pres-Co.) has ,0.02% cross-reactivity with other dienoic
prostanoid metabolites and long-chain polyunsaturated ence of 2% serum, there was no change in malondialde-
hyde concentration as compared with control cells.fatty acids. The enzyme immunoassay system employed
has an excellent correlation (r 5 0.99) with gas chro- Moreover, PDGF did not influence malondialdehyde
levels in mesangial cells grown in 2% serum. Accord-matography/mass-spectrometry, as previously described
[30]. Individual measurements of PGE2 and TXB2 were ingly, for all experiments involving DNA synthesis, cells
were rendered quiescent in the presence of 2% serum,corrected for percentage recoverability by adding a
known quantity of 3H-PGE2 or 3H-TXB2 to the samples. ensuring that lipid radical formation remained constant
irrespective of the concentration of EPA employed.
Statistical analysis Cell membrane remodeling induced by EPA sup-
pressed PDGF-stimulated 3H-thymidine incorporationAll variables were screened using indices of kurtosis
and skewness to ensure that the distribution was approxi- (Fig. 2). Although control cells and cells treated with 10
mg/mL of EPA exhibited a threefold increase in 3H-mately Gaussian. When the mean of two groups was
compared, the Student’s t-test was employed. When the thymidine incorporation, cells grown in media enriched
with $20 mg/mL of EPA exhibited a marked attenuationmean of three groups was compared, analysis of variance
was employed, followed by the Bonferroni–Dunn multi- of 3H-thymidine uptake. Indeed, cells pretreated with
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Table 1. Concentration (%) of major phospholipid fatty acids in the membrane fraction of cultured glomerular mesangial cells
EPA in media Palmitic Stearic Oleic Cis-vaccinic Linoleic Arachidonic EPA
3 488 % % % % % % %
lg/mL (16:0) (18:0) (18:1, v-9) (18:1, v-7) (18:2, v-6) (20:4, v-6) (20:5, v-3)
0 (N 5 10) 29.1861.1 28.362.73 9.661.22 3.9760.56 2.0460.23 18.1963.17 0.560.02
10 (N 5 10) 27.5960.98 23.163.91 11.1763.29 3.3960.87 2.1460.35 15.6962.26a,b 3.2261.11a,b
20 (N 5 10) 25.6563.17 23.2462.97 12.1462.0 4.5660.9 2.4160.6 10.6961.44a 9.0260.55a,b
30 (N 5 10) 31.4364.5 25.1163.44 10.3862.29 3.1260.5 1.8160.3 7.0860.93a,b 11.9160.78a,b
50 (N 5 10) 23.6563.12a,b 19.3260.98a,b 5.9660.7 3.2760.44 1.9160.23 3.5560.30a,b 17.0260.52a,b
Abbreviation: EPA is eicosapentaenoic acid.
a , P 0.05 vs. other groups
b , P 0.05 vs. control (0 mg/ml)
Fig. 1. Lipid peroxidation in cultured mesangial cells incubated with
varying concentrations of eicosapentaenoic acid (EPA) and fetal calf
sera (FCS). Symbols are: (s) 0% FCS; (d) 2% FCS 1 PDGF; ( )
2% FCS; (h) 17% FCS. Lipid endoperoxide formation was quantitated Fig. 2. Effects of platelet-derived growth factor-BB (PDGF-BB) on
as thiobarbituric acid-reactive substances, for example, malondialde- 3H-thymidine incorporation in mesangial cells enriched with eicosapen-
hyde (MDA). *†P , 0.01 vs. other groups (ANOVA). **P , 0.05 vs. taenoic acid. Symbols are: (h) 3H-thymidine incorporation in mesangial
0 mg/mL and 10 mg/mL (paired t-test). The results represent the mean cells rendered quiescent in 2% delipidated fetal calf serum and enriched
of six determinations for each condition. with eicosapentaenoic acid; ( ) 3H-thymidine incorporation in quies-
cent mesangial cells stimulated with PDGF-BB for 24 hours (20 ng/mL
media). *P , 0.01 vs. corresponding quiescent cells. †P , 0.01 vs.
PDGF-stimulated control cells (0 mg/mL) and cells enriched with 10
mg/mL eicosapentaenoic acid. The results represent the mean of 12
50 mg/mL of EPA exhibited an insignificant rise in 3H- determinations for each condition. Qualitatively similar results were
obtained using a cell proliferation assay kit and counting cells with athymidine uptake as compared with quiescent cells.
hemocytometer (data not shown).
Study 2
It was hypothesized that the antiproliferative effect of
EPA was incident to altered prostaglandin biosynthesis cells grown in the presence of media enriched with 50
mg/mL of EPA demonstrated an insignificant increaseas a result of membrane fatty acid remodeling, for exam-
ple, particularly a decrease in arachidonic acid content. in TXB2 (and growth) compared with unstimulated cells
(81.2 6 12.3 to 127.1 6 0.6 pg/mL). In contrast, PDGF-The administration of PDGF was associated with a sig-
nificant increase in PGE2 (70.4 6 4.9 to 243.8 6 9.8 stimulated PGE2 concentration remained constant over
the dose range of EPA employed in these studies.pg/mL) and TXB2 (67.0 6 9.9 to 255.3 6 9.8 pg/mL) in
the supernatant of cultured mesangial cells grown in the To substantiate that TXA2 promotes growth in cul-
tured mesangial cells, the TXA2 mimetic, U-46619 (Cay-absence of EPA (Fig. 3). Similar increases in TXB2 and
PGE2 were observed in cells pretreated with 10 mg/mL man Chemical Co.) was administered (1 mmol/L) to qui-
escent untreated mesangial cells, and 3H-thymidineof EPA. However, cells pretreated with $20 mg/mL of
EPA exhibited a decrease in TXB2 generation, which uptake was determined (Fig. 3, inset). A 120% increase
in 3H-thymidine uptake was observed in mesangial cellsparalleled the decrease in cell growth (Fig. 2). Indeed,
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Fig. 3. Effects of PDGF-BB on TXA2 (h) and PGE2 (s)
synthesis in mesangial cells incubated in control media and
media enriched with eicosapentaenoic acid. †P , 0.01 vs.
unstimulated control cells (2PDGF). *P , 0.01 vs. PDGF-
stimulated control cells (1PDGF). (Inset) Effects of TXA2
mimetic, U-46619 (1 mmol/L), on 3H-thymidine incorporation
in cultured glomerular mesangial cells. *P , 0.05 vs. controls.
The results represent the mean of 10 determinations for each
condition.
following the administration of U-46619. Thus, the paral- mmol/L) indomethacin. In contrast, TXB2 was reduced
by 5, 29, and 75% in cells treated with 0.1, 1, and 100lel decrease in TXB2 and DNA synthesis in remodeled
cells suggests that EPA suppressed mesangial cell prolif- mmol/L indomethacin, respectively, values that closely
paralleled the decrease in 3H-thymidine incorporation.eration by reducing the synthesis of TXA2. It was then
reasoned that pharmacological blockade of TXA2 syn- Although these findings are consistent with the hypothe-
sis that alterations in TXA2 participate in growth regula-thesis would similarly arrest mesangial cell growth in-
duced by PDGF. tion in mesangial cells subjected to stimulation with
PDGF, it was not possible to exclude the effects of al-
Study 3 tered PGE2 or other unmeasured cyclooxygenase metab-
olites in the genesis of these findings. Therefore, selectiveThe blockade of cyclooxygenase with indomethacin
inhibition of thromboxane synthase was also carried outinduced a decrease in mesangial cell proliferation in re-
in mesangial cells treated with the specific thromboxanesponse to PDGF (Fig. 4A). In contrast to the threefold
synthase inhibitor U-63557A [20]. U-63557A attenuatedincrease in 3H-thymidine uptake observed in control
3H-thymidine incorporation by 11, 58, and 72% in cellscells, 3H-thymidine incorporation was decreased by 12,
pretreated with 0.1, 10, and 100 mmol/L U-63557A, re-27, and 71% in cells pretreated with 0.1, 1.0, and 100
spectively (Fig. 5A). As a corollary, TXB2 synthesis wasmmol/L of indomethacin, respectively. Indeed, 3H-thymi-
reduced from 202.1 6 20.1 pg/mL to 170.1 6 25.3, 109.1 6dine incorporation was negligible in cells pretreated with
15.3, and 61.0 6 8.7 pg/mL at 0.1, 10, and 100 mmol/L100 mmol/L indomethacin. As expected, decrements in
U-63557A, respectively (Fig. 5B). The decrease in TXB2prostaglandin synthesis were also observed in cells
paralleled the reduction in DNA synthesis obtained withtreated with indomethacin (Fig. 4B). Although PDGF
U-63557A. Moreover, in contrast to nonspecific block-increased both PGE2 and TXB2 in control mesangial cells
ade of cyclooxygenase with indomethacin, U-63557A re-(87.2 6 20 to 202.4 6 25.1 pg/mL, TXB2; 41.2 6 4.3 to
sulted in no change in PGE2 synthesis.181.2 6 7.6 pg/mL, PGE2), treatment of the cells with
indomethacin abolished the increment of PGE2 and
Study 4blunted that of TXB2. PGE2 was more sensitive to the
blockade of cyclooxygenase, as the increase observed in Coincubation of U-46619 (1 mmol/L) with PDGF in
cells remodeled via exposure to EPA restored growthcontrol cells was completely abrogated in cells treated
with low-dose (0.1 mmol/L) as well as high-dose (100 to 75 to 80% of control values (Fig. 6). Thus, there was
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Fig. 4. Effects of treatment with indometha-
cin 3 248 on PDGF-stimulated DNA and
prostaglandin synthesis. (A) The open bars
(Go) represent 3H-thymidine incorporation in
cells rendered quiescent in 2% fetal calf serum
3 488. Hatched bars represents 3H-thymidine
incorporation in PDGF-stimulated control
(Con) cells. Shaded bars represent 3H-thymi-
dine incorporation in PDGF-stimulated cells
treated with increasing concentrations of in-
domethacin (indo). *P , 0.01 vs. Go; †P ,
0.05 vs. Con. (B) PGE2 (s) and TXB2 (h)
concentration in cells rendered quiescent in
2% fetal calf serum (Go) vs. PDGF-stimulated
control cells (Con) and cells treated with indo-
methacin (indo). *P , 0.01 vs. Go; †P , 0.01
vs. Con. The results represent the mean of six
determinations for each condition.
Fig. 5. Effects of treatment with the TXA2
synthase antagonist U-63557A 3 248 on
PDGF-stimulated DNA and prostaglandin
synthesis. (A) Symbols are: (h) 3H-thymidine
incorporation in cells rendered quiescent in
2% fetal calf serum 3488 (Go); ( ) 3H-thymi-
dine incorporation in PDGF-stimulated con-
trol (Con) cells; ( ) 3H-thymidine incorpora-
tion in PDGF-stimulated cells treated with
U-63557A. *P , 0.01 vs. Go; †P , 0.01 vs.
Con. (B) PGE2 (s) and TXB2 (h) concentra-
tion in cells rendered quiescent in 2% fetal
calf serum (Go) vs. PDGF-stimulated control
cells (Con) and cells treated with U-63557A.
*P , 0.01 vs. Go; †P , 0.01 vs. Con. The
results represent the mean of six determina-
tions for each condition.
a 250 6 24% increase in DNA synthesis in control cells [2]. The effects of v-3 fatty acids on cell growth are of
and cells pretreated with 10 mg/mL of EPA. The latter considerable importance because the management of a
response was essentially unchanged with the addition variety of chronic medical diseases (for example, athero-
of U-46619. However, the decrease in DNA synthesis sclerosis, cancer, and progressive renal disease) is be-
observed in cells treated with $20 mg/mL of EPA was lieved to be amenable to agents that modulate cell
abrogated by coincubation of PDGF with U-46619, sug- growth. For example, recent studies have suggested that
gesting that the inhibitory effect of EPA at concentra- the proliferating mesangial cell promotes renal injury by
tions of $20 mg/mL is specifically mediated by inhibition altering the dynamics of matrix turnover, resulting in the
of TXA2 synthesis. accumulation of extracellular matrix components even-
tuating in glomerular scarring [31–35]. Thus, the purpose
of this investigation was threefold: (1) to assess the mito-DISCUSSION
genic response of cultured glomerular mesangial cellsv-3 Fatty acids derived from fish oil exert beneficial
exposed to the major v-3 fatty acid present in marineeffects on organ physiology and pathophysiology by al-
oil, for example, EPA; (2) to determine the relationshiptering endogenous cellular functions, including eicosa-
of altered membrane fatty acid content induced by EPAnoid synthesis, growth, and differentiation, presumably
as a result of altered plasma membrane lipid composition on mitogenesis in mesangial cells; and (3) to determine
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prostaglandin metabolites. Indeed, such a phenomenon
is postulated to underlie the decrease in dienoic prosta-
glandin synthesis observed following the uptake of v-3
fatty acids by cell membranes [1]. In these studies, we
observed a decrease in TXB2, which accompanied the
decrease in arachidonic acid content. However, the fore-
going relationship was not apparent until the membrane
content of arachidonic acid decreased from 15.69 to
10.69% (Table 1), suggesting that substrate availability
only limits the synthesis of TXA2 when sufficiently re-
duced. Surprisingly, we did not observe a decrease in
supernatant PGE2 in cells pretreated with EPA. The
reason(s) for this apparent paradox cannot be answered
by these investigations; however, because the antisera
used to detect PGE2 exhibits 100% cross-reactivity with
PGE3 (personal communication; Cayman Chemical Co.),
it is possible that the concentration of PGE2 was overesti-
mated.
Fig. 6. Effects of PDGF-BB or PDGF-BB 1 U-46619 on DNA synthe-
An important finding in our investigation was the sup-sis in mesangial cells enriched with eicosapentaenoic acid. Symbols are:
(h) 3H-thymidine incorporation in mesangial cells rendered quiescent pression of mitogenesis induced by remodeling the phos-
in 2% delipidated fetal calf serum with or without eicosapentaenoic acid; pholipid fatty acid pool of the mesangial cell membrane.
( ) 3H-thymidine incorporation in quiescent mesangial cells stimulated
Several studies have demonstrated growth suppressionwith PDGF-BB for 24 hours (20 ng/mL media); (j) 3H-thymidine
incorporation in quiescent mesangial cells stimulated with PDGF-BB in cultured cells exposed to v-3 fatty acids, for example,
(20 ng/mL) and U-46619 (1 mmol/L) for 24 hours. *P , 0.01 vs. corre- lymphocytes, vascular smooth muscle cells, keratino-
sponding quiescent cells; †P , 0.01 vs. PDGF-stimulated control cells
cytes, and recently glomerular mesangial cells [10]. How-(0 mg/mL) and cells enriched with 10 mg/mL eicosapentaenoic acid.
‡P , 0.05 vs. corresponding PDGF stimulated mesangial cells without ever, the latter studies failed to examine membrane fatty
U-46619 ( ). The results represent the mean of 12 determinations for acid composition and its relationship to DNA synthesis.
each condition. Qualitatively similar results were obtained using a cell
In addition, previous studies frequently incubated PDGFproliferation assay kit and counting cells with a hemocytometer (data
not shown). in media containing EPA, raising the possibility that the
results were influenced by a detergent-like effect of EPA
on PDGF binding to cell surface receptors [39]. More-
over, the methodology employed to enrich cells with
the contribution of altered endogenous TXA2 synthesis EPA often involved the incubation of fatty acids as free
to growth suppression. salts or methyl ester derivatives. The latter compounds
The incorporation of EPA into the mesangial cell may facilitate free radical formation and induce direct
phospholipid pool increased as a function of media con- cellular injury. Our studies circumvented the latter prob-
centration and was accompanied by a parallel, albeit lem through the use of EPA-albumin conjugates. This
reciprocal decrease in phospholipid-derived arachidonic strategy allows transfer of fatty acids to cells in a manner,
acid. Such a phenomenon demonstrating an inverse rela- which is analogous to that attained in vivo [23]. More-
tionship between the tissue incorporation of v-3 and v-6 over, our cells were washed copiously to remove residual,
fatty acids is in accord with previous studies from our unbound EPA before stimulating with PDGF, thus elimi-
laboratory [29, 36]. The maintenance of a relatively con- nating a detergent-like effect. Hence, we conclude that
stant membrane unsaturation index is consistent with our paradigm of fatty acid remodeling more closely par-
the natural tendency of cell membranes to regulate their allels the effects of dietary manipulations of fatty acids
physical properties such as membrane fluidity; however, employed in vivo.
the precise cellular mechanism responsible for these ad- The decrease in TXB2 coupled with a parallel reduc-
justments remains incompletely understood [37]. None- tion in cell growth is consistent with the hypothesis that
theless, enzyme-catalyzed transfer of fatty acids from EPA mediates growth suppression via altered endoge-
acyl-CoA ester to phospholipids is kinetically similar nous synthesis of TXA2. Recently, TXA2 has been shown
for EPA and arachidonic acid, and thus, the relative to act as a mitogen in several cell lines, including glomer-
abundance of EPA/arachidonic acid in the media is a ular mesangial cells [18, 19], albeit the amplitude of DNA
major factor influencing the fatty acid composition of synthesis is typically modest unless coadministered with
the tissue [1, 38]. A consequence of fatty acid remodeling PDGF [40]. Hence, TXA2 may play an important permis-
induced by EPA is the concomitant decrease in substrate sive role in promoting mesangial cell growth by ampli-
fying the growth response of endogenous polypeptideavailable (arachidonic acid) for the synthesis of dienoic
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growth factors [9, 41, 42]. For example, synthetic prosta- TXA2 synthesis is only limited by substrate availability
when the precursor is reduced to levels that modulateglandins, particularly TXA2, act as comitogens with poly-
peptide growth factors in several in vitro assay systems kinetic regulation of TXA2 synthesis (rate limiting) [48].
Moreover, other pathways involved in the liberation of[43]. In addition, inhibition of cyclooxygenase and
thromboxane synthase in cultured glomerular epithelial arachidonic acid, including those coupled to diacylglyc-
erol/monoacylglycerol lipase, may influence arachidoniccells attenuates the proliferative response to polypeptide
growth factors [42]. Interestingly, recent studies have acid release in this setting.
Importantly, lipid endoperoxide formation measuredsuggested that PDGF induces arachidonic acid release
from cell membrane fatty acid pools via the activation as malondialdehyde concentration remained constant in
cells exposed to increasing concentrations of EPA. Al-of phospholipase A2 [44–46].
To further investigate the potential role of TXA2 in though determination of malondialdehyde yields a crude
index of lipid peroxidation, the small standard deviationmodulating mesangial cell proliferation, cells were sub-
jected to pharmacological inhibition of TXA2 synthesis and consistent trends suggest that it is highly unlikely
that the growth suppression subsequently observed inwith the cyclooxygenase inhibitor indomethacin and the
specific thromboxane synthase inhibitor U-63557A. This cells remodeled with EPA was attributable to an alter-
ation in lipid radical formation. The corresponding de-approach served to vary the synthesis of PGE2 (Figs. 4
and 5), thus dissociating the effects of PGE2 from TXB2 crease in arachidonic acid in cells enriched with EPA
likely attenuated the expected increase susceptibility toand the attendant growth alteration. Although both in-
domethacin and U-63557A inhibited mesangial cell peroxidative attack [49].
In summary, PDGF-stimulated DNA synthesis wasgrowth in a dose-dependent manner, PGE2 decreased
after treatment with indomethacin but remained un- suppressed in mesangial cells chronically exposed to me-
dia enriched with EPA. Because the decrease in mesan-changed after treatment with U-63557A [47]. Hence,
alterations in PGE2 synthesis do not appear to correlate gial cell proliferation was accompanied by a parallel fall
in TXA2 and the TXA2 mimetic U-46619 restored thewith the growth-suppressive effects of indomethacin and
U-63557A. In contrast, TXB2 was decreased by both proliferative response, we conclude that EPA contrib-
utes to growth suppression by decreasing the synthesiscompounds, an effect that was qualitatively similar to
the decrease in DNA synthesis observed in cells enriched of PDGF-stimulated TXA2. As a corollary, nonspecific
(indomethacin) and specific inhibition (U-63557A) ofwith EPA. Importantly, coadministration of the TXA2
mimetic U-46619 with PDGF-BB restored DNA synthe- TXA2 synthesis also attenuated PDGF-stimulated mes-
angial cell growth. Nonetheless, our studies do not allowsis to 60 to 80% of normal in cells remodeled with EPA.
Collectively, these studies are consistent with the hypoth- us to conclude that altered TXA2 synthesis is the exclu-
sive mechanism responsible for growth suppression inesis that EPA suppresses mesangial cell proliferation via
modulation of endogenous TXA2 synthesis incurred by cells modified by the uptake of EPA. Accordingly, modu-
lation of other signal transduction pathways or ligand–a rate-limiting decrease in its precursor, arachidonic acid.
Interestingly, the growth suppression of glomerular receptor interactions may also participate in this behav-
ior [2, 4, 5]. For example, EPA has been shown tomesangial cells was not observed at low doses of EPA
(10 mg/mL of media), corresponding to a membrane competitively inhibit the binding of PDGF to mesangial
cell surface receptors and possibly decrease endothelin-1content of arachidonic acid of 15.69%. Furthermore, the
latter was insufficient to alter basal or stimulated TXB2 secretion [10]. Whether these effects occur as a conse-
quence of cell incorporation versus direct competitionconcentration. In contrast, at concentrations of $20
mg/mL media, EPA elicited a decrease in mesangial cell for cell surface receptors by fatty acids present in the
supernatant has not been fully characterized.proliferation that paralleled the decrease in supernatant
TXB2. The dose–response relationship of these results Because exposure to $20 mg/mL of EPA was required
to reduce growth, we conclude that membrane remodel-is of considerable significance because in vivo studies
using diets enriched with EPA may produce varying re- ing plays a pivotal role in modulating cell division. Ac-
cordingly, these studies underscore the importance ofsults subject to tissue remodeling induced by EPA. Be-
cause the hydrolytic specificity of the 85 kD cytosolic characterizing the membrane composition induced by
fatty acid remodeling in relationship to a particular bio-phospholipase A2 for phospholipids containing EPA is
comparable to phospholipids containing arachidonic logical response. The latter is of great importance, as
extrapolation of in vitro findings to in vivo models ofacid, the liberation of arachidonic acid should fundamen-
tally decrease in concert with membrane remodeling disease must be tempered by knowledge of the obliga-
tory dose and/or tissue composition necessary to evokeinduced by EPA [15, 16]. Thus, the dissociation of arachi-
donic acid content and TXA2 synthesis at low con- a response.
Finally, the in vitro findings in these studies raise thecentrations of EPA (10 mg/mL) is a paradox not readily
answered by these studies. However, it is likely that attractive possibility that the beneficial effects exerted
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